

MAP Pharmaceuticals Email Formats
Pharmaceutical Manufacturing • United States • 101-200 Employees
MAP Pharmaceuticals Email Formats
MAP Pharmaceuticals uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 51.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 51.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 21.8% |
{first name}@company.com | john@company.com | 11.2% |
{last name}.{first name}@company.com | doe.john@company.com | 9.1% |
{first name}_{last name}@company.com | john_doe@company.com | 6.6% |
Key Contacts at MAP Pharmaceuticals
Paul Boyd
Founder And Director
Ashish Kesari
Owner
Steve Massah
Director Manufacturing
方友 高
Project Director
Travis Bickle
It Director
Maria Martinez
Director De Proyecto
Larrain Taberna
Director De Ventas
Marcor Reina Cortena
Director
Company overview
| Headquarters | United States |
| Phone number | +16503863100 |
| Website | |
| NAICS | 3254 |
| Founded | 2005 |
| Employees | 101-200 |
| Socials |
About MAP Pharmaceuticals
MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX™ inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
MAP Pharmaceuticals has 53 employees across 12 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



